# IEIK13 For Neurosurgery

> **NCT04953949** · NA · COMPLETED · sponsor: **3-D Matrix Europe SAS** · enrollment: 80 (actual)

## Conditions studied

- Oozing (Hemorrhage) During Intracranial Procedures

## Interventions

- **DEVICE:** NU-MAX®

## Key facts

- **NCT ID:** NCT04953949
- **Lead sponsor:** 3-D Matrix Europe SAS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-06
- **Primary completion:** 2023-08-04
- **Final completion:** 2023-11-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04953949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04953949, "IEIK13 For Neurosurgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04953949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*